Episode Details

FDA Commissioner Marty Makary is stepping down amidst internal clashes and pressure from various groups, including the White House and pharma companies. His departure comes after a tumultuous tenure marked by nonstop turnover in top ranks, controversial decisions on e-cigarettes, and disagreements on drug approvals and policies. The shake-up could potentially improve relations with key players in drugs and social conservative circles, setting the stage for health policy fights ahead of Novembers elections.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/0d405c73a9ccd490